Priligy Approval Status
- FDA approved: No
- Brand name: Priligy
- Generic name: dapoxetine
- Company: ALZA Corporation
- Treatment for: Premature Ejaculation
Priligy (dapoxetine) is a short-acting selective serotonin reuptake inhibitor (SSRI) under review for the treatment of premature ejaculation.
Development Status and FDA Approval Process for Priligy
|Oct 26, 2005||ALZA Corporation Receives Letter From FDA on Dapoxetine Application|
|Dec 4, 2004||New Drug Application Submitted for Dapoxetine for Premature Ejaculation|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.